Thursday, November 12, 2015

Anticoagulant Use Among Afib Patients Wanes Over Time (CME/CE)

(MedPage Today) -- Rivaroxaban has marginally better persistence rates versus other agents
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)